Clinical Study
Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin
Table 1
Clinical characteristics of prostate cancer and benign prostatic hyperplasia patients.
| Clinical variable | Prostate cancer patients | BPH patients |
| Age (y) | | | Mean | 67 | 66 | Median | 70 | 66.5 | Range | 55–78 | 53–78 | Preoperative PSA (ng/mL) | | | Median | 13 | 2.98 | Range | 1.2–487 | 0.65–65 | TNM stage | | | Stage T1a | 0 (0%) | | Stage T1b | 4 (15%) | | Stage T1c | 3 (11%) | | Stage T2a | 7 (26%) | | Stage T2b | 3 (11%) | | Stage T2c | 3 (11%) | | Stage T3a | 7 (30%) | | Gleason score | | | 5 | 2 (7%) | | 6 | 9 (33%) | | 7 | 6 (22%) | | 8 | 4 (16%) | | 9 | 6 (22%) | | Lymph node involvement | 2 (7%) | | Seminal vesicle involvement | 6 (22%) | | Distant metastasis | 4 (15%) | | Total | 27 | 24 |
|
|